1661 related articles for article (PubMed ID: 15336577)
1. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients.
Ersöz HO; Ukinc K; Köse M; Erem C; Gunduz A; Hacihasanoglu AB; Karti SS
Int J Clin Pract; 2006 Apr; 60(4):429-33. PubMed ID: 16620355
[TBL] [Abstract][Full Text] [Related]
3. Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.
Reichel A; Rietzsch H; Köhler HJ; Pfützner A; Gudat U; Schulze J
Exp Clin Endocrinol Diabetes; 1998; 106(3):168-72. PubMed ID: 9710355
[TBL] [Abstract][Full Text] [Related]
4. Mandatory protocol for treating adult patients with diabetic ketoacidosis decreases intensive care unit and hospital lengths of stay: results of a nonrandomized trial.
Bull SV; Douglas IS; Foster M; Albert RK
Crit Care Med; 2007 Jan; 35(1):41-6. PubMed ID: 17095944
[TBL] [Abstract][Full Text] [Related]
5. Use of lispro insulin for treatment of diabetic ketoacidosis in dogs.
Sears KW; Drobatz KJ; Hess RS
J Vet Emerg Crit Care (San Antonio); 2012 Apr; 22(2):211-8. PubMed ID: 22390184
[TBL] [Abstract][Full Text] [Related]
6. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies.
Vincent M; Nobécourt E
Diabetes Metab; 2013 Sep; 39(4):299-305. PubMed ID: 23642642
[TBL] [Abstract][Full Text] [Related]
7. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.
Umpierrez GE; Cuervo R; Karabell A; Latif K; Freire AX; Kitabchi AE
Diabetes Care; 2004 Aug; 27(8):1873-8. PubMed ID: 15277410
[TBL] [Abstract][Full Text] [Related]
8. Serum glucose changes during insulin therapy in pediatric patients with diabetic ketoacidosis.
Bradley P; Tobias JD
Am J Ther; 2007; 14(3):265-8. PubMed ID: 17515702
[TBL] [Abstract][Full Text] [Related]
9. Treatment of diabetic ketoacidosis in dogs by continuous low-dose intravenous infusion of insulin.
Macintire DK
J Am Vet Med Assoc; 1993 Apr; 202(8):1266-72. PubMed ID: 8496083
[TBL] [Abstract][Full Text] [Related]
10. Utility of initial bolus insulin in the treatment of diabetic ketoacidosis.
Goyal N; Miller JB; Sankey SS; Mossallam U
J Emerg Med; 2010 May; 38(4):422-7. PubMed ID: 18514472
[TBL] [Abstract][Full Text] [Related]
11. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
Razavi Z; Maher S; Fredmal J
Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
[TBL] [Abstract][Full Text] [Related]
12. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
Chant C; Wilson G; Friedrich JO
Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
[TBL] [Abstract][Full Text] [Related]
13. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
Umpierrez GE; Smiley D; Zisman A; Prieto LM; Palacio A; Ceron M; Puig A; Mejia R
Diabetes Care; 2007 Sep; 30(9):2181-6. PubMed ID: 17513708
[TBL] [Abstract][Full Text] [Related]
14. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment.
Kreisel SH; Berschin UM; Hammes HP; Leweling H; Bertsch T; Hennerici MG; Schwarz S
Cerebrovasc Dis; 2009; 27(2):167-75. PubMed ID: 19092238
[TBL] [Abstract][Full Text] [Related]
15. Lowering of glucose in critical care: a randomized pilot trial.
McMullin J; Brozek J; McDonald E; Clarke F; Jaeschke R; Heels-Ansdell D; Leppert R; Foss A; Cook D
J Crit Care; 2007 Jun; 22(2):112-8; discussion 118-9. PubMed ID: 17548021
[TBL] [Abstract][Full Text] [Related]
16. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia.
Staszewski J; Brodacki B; Kotowicz J; Stepien A
J Stroke Cerebrovasc Dis; 2011; 20(2):150-4. PubMed ID: 20621520
[TBL] [Abstract][Full Text] [Related]
17. Utilizing serum bicarbonate instead of venous pH to transition from intravenous to subcutaneous insulin shortens the duration of insulin infusion in pediatric diabetic ketoacidosis.
Gauntt J; Vaidyanathan P; Basu S
J Pediatr Endocrinol Metab; 2019 Jan; 32(1):11-17. PubMed ID: 30530908
[TBL] [Abstract][Full Text] [Related]
18. Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects.
Becker RH; Frick AD; Burger F; Potgieter JH; Scholtz H
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):435-43. PubMed ID: 16151977
[TBL] [Abstract][Full Text] [Related]
19. Initial experience with an intensive care hyperglycemia protocol in a Saudi Arabian intensive care unit.
Iqbal M; Al-Aithan AM; Rehmani R; Eledrisi M
Saudi Med J; 2006 Apr; 27(4):492-6. PubMed ID: 16598326
[TBL] [Abstract][Full Text] [Related]
20. Diabetic ketoacidosis: low-dose insulin therapy by various routes.
Fisher JN; Shahshahani MN; Kitabchi AE
N Engl J Med; 1977 Aug; 297(5):238-41. PubMed ID: 406561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
